Co-Authors
This is a "connection" page, showing publications co-authored by Aldo Bonaventura and Brenna Carey.
Connection Strength
0.281
-
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies. Front Immunol. 2020; 11:1625.
Score: 0.223
-
Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial. Lancet Rheumatol. 2021 Jun; 3(6):e410-e418.
Score: 0.058